Related Experiment Videos
Sudden unexpected death in epilepsy: a local audit
1Dept of Pharmacology and Therapeutics, University of Wales College of Medicine, Health Park, Cardiff, UK.
Seizure
|December 1, 1993
Summary
Sudden unexpected death in epilepsy (SUDE) affects approximately 1 in 500 patients annually, with males and those with generalized tonic-clonic seizures being more susceptible. Further research is needed to accurately determine SUDE incidence and risk factors.
Area of Science:
- Neurology
- Epilepsy Research
- Public Health
Background:
- Sudden unexpected death in epilepsy (SUDE) is an under-investigated cause of mortality.
- Limited prospective studies exist on SUDE incidence and contributing factors.
Purpose of the Study:
- To audit data from the Cardiff Epilepsy Unit to identify SUDE cases.
- To analyze demographic and clinical characteristics of SUDE patients.
- To compare SUDE patient profiles with the general epilepsy patient population.
Main Methods:
- Retrospective audit of 7000 patient-treatment years at the Cardiff Epilepsy Unit.
- Identification of 14 SUDE cases.
- Comparison of SUDE cases with over 1820 other epilepsy patients.
Main Results:
- SUDE incidence estimated at 1 in 500 patients per year.
- Males were twice as likely to be affected as females.
- SUDE patients were significantly more likely to have idiopathic generalized tonic-clonic seizures and use carbamazepine compared to other epilepsy patients.
Conclusions:
- SUDE appears more prevalent in males with generalized tonic-clonic seizures, particularly those on carbamazepine.
- Accurate identification and prospective studies are crucial for understanding SUDE.
- Further research is needed to ascertain true incidence, risk factors, and causes of SUDE.